Healthcare and Life Science
UK-China Life Sciences Forum in London: Fostering practical collaboration
On 10 June 2025, the “Sino-UK Pharmaceutical Cooperation Partnering Conference” convened at the Millennium Gloucester Hotel in London, providing a valuable forum for professionals and organisations from both the UK and China to explore new opportunities in life sciences and healthcare i...
Accelerate@Babraham 2025 announces new cohort
Five new ventures secure the chance to be part of Babraham Research Campus - a leading location for early-stage life science start-ups. ...
New Non-Executive Director appointed to CUH
Philippa Hird has been appointed as a Non-Executive Director of Cambridge University Hospitals NHS Foundation Trust (CUH), which runs Addenbrooke’s and The Rosie Hospitals. ...
CUH lands double funding win for technology
Two cutting-edge medical technologies from Addenbrooke's to tackle brain injury are among 35 awarded a share of £3m from the National Institute for Health and Care Research (NIHR). ...
25 years since the completion of the human genome project and the future of genomics
As it marks 25 years since the Human Genome Project, the Sanger Institute looks to a future where genomics drives better health and prevents disease. ...
Simple and accurate clinic vision self-test is UK first
Addenbrooke’s has become the first UK hospital to use digital technology that enables patients to test their own vision in minutes while waiting to see their eyecare clinician. ...
Turning trade tensions into opportunity: How UK businesses can lead in the medical device sector
Disclaimer: This article is intended for industry professionals and provides general educational information only. It does not promote specific products or constitute medical advice. ...
Goodwin Advised Harbour BioMed in $175 Million Global Strategic Collaboration with AstraZeneca to Discover and Develop Next-Generation Therapeutic Antibodies
The Life Sciences team advised Harbour BioMed on a global strategic collaboration with AstraZeneca to discover and develop next-generation multi-specific antibodies for immunology, oncology, and beyond. The strategic collaboration includes an option to license multiple programs u...
STEMCELL Technologies announces acquisition of Cellular Highways
Vancouver, British Columbia and Cambridge, United Kingdom, June 02, 2025 – STEMCELL Technologies, Canada’s largest biotechnology company, is pleased to announce the acquisition of Cellular Highways Ltd from TTP Group Ltd. Cellular Highways is a biotechnology company based near Cambridge...
Music therapy may reduce distress for people with dementia
Research with CPFT finds that a new treatment approach using music therapy on NHS dementia wards could improve care and support for some of the most vulnerable NHS patients. ...